Stanford University
Showing 21-30 of 351 Results
-
Nasim Bararpour
Basic Life Research Scientist, Genetics
BioNasim Bararpour is a postdoctoral fellow in the Department of Genetics and Personalized Medicine at Stanford School of Medicine, where she works at the intersection of data science, and multi-omics integration. She completed her Ph.D. in Life Science from the University of Lausanne, developing deep expertise in mass spectrometry-based metabolomics and lipidomics as well as integrative omics. She joined Stanford in 2020.
At Stanford, Dr. Bararpour has led and contributed to some of the most comprehensive multi-omics studies to date, including the human Personalized Omics Profiling (hPOP) project, the integrative Personal Omics Profiling (iPOP) study, and the Human Tumor Atlas Network (HTAN). Her first-authored paper in Cell (2026), which integrated thirteen molecular layers across individuals of diverse ancestries, identified ethnicity-specific drug target patterns and molecular pathways with direct implications for cardiometabolic disease, making a scientific case for population-aware precision medicine. She is the author of over 20 peer-reviewed publications, including papers in Nature Metabolism, and Nature Biomedical Engineering. -
Maria Barna
Associate Professor of Genetics
Current Research and Scholarly InterestsThe Barna Lab studies how gene expression is controlled at the level of translation to shape development, regeneration, and disease.For decades, ribosomes were viewed as uniform molecular machines that passively translate genetic information. Our work helped overturn this paradigm by demonstrating that ribosomes can differ in composition and function, giving rise to specialized translation programs that regulate cell fate and organismal development. By integrating genomics, mass spectrometry,
-
Greg Barsh
Professor of Genetics and of Pediatrics, Emeritus
Current Research and Scholarly InterestsGenetics of color variation
-
Michael Bassik
Associate Professor of Genetics
Current Research and Scholarly InterestsWe are an interdisciplinary lab focused on two major areas:(1) we seek to understand mechanisms of cancer growth and drug resistance in order to find new therapeutic targets(2) we study mechanisms by which macrophages and other cells take up diverse materials by endocytosis and phagocytosis; these substrates range from bacteria, viruses, and cancer cells to drugs and protein toxins. To accomplish these goals, we develop and use new technologies for high-throughput functional genomics.
